Cladribine

FDA Approved: * February 28, 2000
Pharm Company: * BEDFORD
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cladribine Overview

Cladribine, sold under the brand name Leustatin and Mavenclad among others, is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis), B-cell chronic lymphocytic leukemia and relapsing-remitting multiple sclerosis.[3][4] Its chemical name is 2-chloro-2'-deoxyadenosine (2CdA). As a purine analog, it is a synthetic chemotherapy agent that targets lymphocytes and selectively suppresses the immune system. Chemically, it mimics the nu...

Read more Cladribine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cladribine

Recent Cladribine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cladribine
  • Injection: 1mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cladribine: (6 results)

Sorted by National Drug Code
  • 0069-0086 Cladribine 1 mg/ml Intravenous Injection by Pfizer Laboratories Div Pfizer Inc.
  • 0069-0201 Cladribine 1 mg/ml Intravenous Injection by Pfizer Laboratories Div Pfizer Inc.
  • 47351-017 Cladribine 1 mg/ml Intravenous Injection by Onco Therapies Limited
  • 63323-140 Cladribine 1 mg/ml Intravenous Injection by Fresenius Kabi USA, LLC
  • 67457-450 Cladribine 1 mg/ml Intravenous Injection by Mylan Institutional LLC
  • 67457-451 Cladribine 1 mg/ml Intravenous Injection by Mylan Institutional LLC

Other drugs which contain Cladribine or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA